The Hair Loss Treatment Manufacturing industry, which produces oral and topical medications as well as restorative hair equipment, has experienced moderate growth over the past five years. Profit in the industry has also grown, despite a patent cliff that has resulted in the loss of market exclusivity for some brand-name drugs. The resulting proliferation of low-cost generic treatments has made industry products more accessible to consumers, and heightened demand has offset lower product prices. Over the next five years, industry revenue will continue to increase, with growth expected to be sustained by research and development of new products.
This industry develops and produces solutions that prevent or restore hair loss. Products in this industry include topical applications, orally ingestible treatments, hair transplants and laser follicle stimulation.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.